RETINAWS was presented on Saturday evening,
May 1, 2010, in the Fort Lauderdale Convention
Center. Below you will find a brief description of
cases presented. RETINAWS was recorded live
and can be watched on www.eyetube.net/Retinaws. We
would like to t…
Author: Retina Today
Standing Inside the Eye
Retina Today eminterviewed Szilárd Kiss, MD, of Weill
Cornell Medical College to learn about how an interactive,
3-D virtual reality technology, is being used to better
understand disease processes in the eye./em
h3Q: What is the CAVE?/h3
Szilárd Kis…
ADHD Rates Rose Among US Children
Nearly one in 10 children in the United States aged 4 to
17 years has been diagnosed with attention-deficit/hyperactivity
disorder (ADHD), according to a recent survey by
the Centers for Disease Control and Prevention (CDC).1
The results suggest that a…
Bevacizumab Reduced Incidence of Postoperative Recurrent Vitreous Hemorrhage in Small Study
One intravitreal injection of bevacizumab (Avastin,
Genentech) reduced the incidence of recurrent postoperative
vitreous hemorrhage after diabetic vitrectomy,
according to a study in Retina.1
Rizwan A. Cheema, MD, FRCS, FRCOphth, of the
Dhahran Eye Spe…
Resequencing Chip Detected 90 Retinal Disease Genes
A group of researchers in the Netherlands have developed
a resequencing chip to detect known and new
sequence changes in 90 retinal disease genes, according
to a study in Ophthalmology.1 The chip is capable of
screening multiple genes simultaneously.
R…
Postoperative Oral Steroids Reduced Subretinal Fluid
Postoperative systemic steroid treatment decreased the
incidence and facilitated the absorption of subretinal fluid (SRF), according to a study in Retina.1 Patients treated
with steroids also had a greater improvement in BCVA.
In the prospective, inter…
Advanced Cell Technology Receives FDA Clearance to Initiate Clinical Trials
Advanced Cell Technology, Inc. (Santa Monica, CA)
announced that it received clearance from the US Food
and Drug Administration (FDA) for the company’s
Investigational New Drug application to treat dry AMD
using retinal pigment epithelial (RPE) cells…
Omega-3-Rich Fish and Shellfish May Protect Against Advanced AMD
The consumption of omega-3-rich fish and shellfish
may protect against advanced AMD, according to a study
in Ophthalmology.1
Bonnielin K. Swenor, MPH, of the Wilmer Eye Institute,
Johns Hopkins University, Baltimore, and colleagues conducted
a cross-se…
Ranibizumab Approved in EU For Vision Loss Due to Diabetic Macular Edema
The European Medicines Agency (EMEA) has granted
Novartis (Basel, Switzerland) a new, broader indication for
ranibizumab (Lucentis, Genentech) to treat patients with
visual impairment due to diabetic macular edema (DME),
according to a company news rel…
Case Western Reserve University Receives NEI Grant
The Departments of Pharmacology and
Ophthalmology and Visual Sciences at Case Western
Reserve University (CWRU) School of Medicine have
received a $10.1 million grant from the National Eye
Institute (NEI) to research and develop new treatments
for reti…
Ifa Systems AG Aquires Inoveon Corporation
Ifa Systems AG (Cologne, Germany), a provider of software
applications in international ophthalmology,
announced the acquisition of Inoveon Corp. (Oklahoma
City, OK), which specializes in detection, staging, and
monitoring of diabetic retinopathy and m…
Ozurdex Reduced Inflammation, Improved Visual Acuity in Uveitic Eyes
The Ozurdex dexamethasone intravitreal implant
(Allergan, Inc.) significantly improved intraocular inflammation
and visual acuity in patients with noninfectious
intermediate or posterior uveitis, according to a study in
the Archives of Ophthalmology.1
…
Study Linking Vaccines to Autism Was Fraud
A study published in The Lancet in 1998 linking the
measles, mumps, and rubella (MMR) vaccine to autism
was “an elaborate fraud,” according to a report in the
BMJ.1
The study,2 published February 28, 1998, was authored
by Andrew Wakefield, MD, and …
Prevalence of AMD on the Decline in US Adults
The prevalence of age-related macular degeneration
(AMD) in US adults is significantly lower today than it
was 15 years ago, according to the results of a nationally
representative, population-based, cross-sectional study
published in the Archives of O…
VEGF Trap-Eye Noninferior to Ranibizumab in Two Phase 3 Trials
In patients with wet age-related macular degeneration
(AMD), all regimens of aflibercept (VEGF Trap-
Eye, Regeneron), including aflibercept dosed every
2 months, achieved the primary endpoint compared
with ranibizumab (Lucentis, Genentech) dosed every
…
Ranibizumab Improved Visual Outcomes in DME
Patients with DME achieved better long-term visual
outcomes when treated with ranibizumab (Lucentis,
Genentech) and focal/grid laser combination therapy
than with ranibizumab or laser alone, according to the
results of the phase 2 READ-2 study publishe…
Pegaptanib Maintained Vision Gains at 2 Years
Pegaptanib sodium injection (Macugen, Eyetech, Inc.)
significantly improved vision in patients with DME and
maintained and expanded vision gains in patients over a
2-year period, according to phase 3 data presented by
Marla B. Sultan, MD, MBA, at the A…
Carl Zeiss Introduces Multispot Photocoagulation Laser
Carl Zeiss Meditec, Inc. (Dublin, CA), introduced the
Visulas 532s Vite photocoagulator at the AAO in Chicago.
The device recently received marketing clearance from
the FDA. According to the company, the Visulas 532s Vite
photocoagulator features varia…
EyeGate to Develop Corticosteroid Solution for Retinal Disorders
EyeGate Pharma (Waltham, MA) announced that it
has received four federal grants totaling nearly $1 million
for programs that focus on the continued clinical development
of EGP-437, a corticosteroid solution administered by the EyeGate II delivery syste…
Single Injection of Bevacizumab Effective in Eyes With Myopic Choroidal Neovascularization
One intravitreal injection of bevacizumab (Avastin,
Genentech) seems to be an effective therapeutic
approach to treat choroidal neovascularization in
highly myopic eyes, according to a study in Retina.1
José M. Ruiz-Moreno, MD, PhD, of the Instituto
O…